Metraipolis › archive › dc_357c321e6ea2

Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report — Europe PMC PMID:42388640

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42388640
DOI: 10.3389/fonc.2026.1844016
License (as archived): solo-consultazione
Archived: 2026-10-19T08:47:03.285Z
SHA-256 of the archived text: 4e0a7a9e2cec0dd3b5005c1aeddd2f56772b0b6340758a902cefa2ee8242f144
Stable URL of this page: https://metraipolis.com/documento/dc_357c321e6ea2

How to cite

Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report — Europe PMC PMID:42388640 — Europe PMC (en), https://europepmc.org/article/MED/42388640 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_357c321e6ea2 (Metraipolis archive dc_357c321e6ea2, sha256 4e0a7a9e2cec0dd3b5005c1aeddd2f56772b0b6340758a902cefa2ee8242f144)

BibTeX

@misc{dc357c321e6ea2,
  title = {Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report — Europe PMC PMID:42388640},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42388640},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_357c321e6ea2; sha256 4e0a7a9e2cec0dd3b5005c1aeddd2f56772b0b6340758a902cefa2ee8242f144},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42388640. Agents can read the archived copy with the MCP tool read_document.